Literature DB >> 12658320

PHARMAC measures savings elsewhere to the health sector.

Scott Metcalfe1, Sean Dougherty, Matthew Brougham, Peter Moodie.   

Abstract

Mesh:

Year:  2003        PMID: 12658320

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


× No keyword cloud information.
  3 in total

1.  Comments on "Simoens, S. Health economic assessment: a methodological primer. Int. J. Environ. Res. Public Health 2009, 6, 2950-2966"-New Zealand in fact has no cost-effectiveness threshold.

Authors:  Scott Metcalfe; Rachel Grocott
Journal:  Int J Environ Res Public Health       Date:  2010-04-20       Impact factor: 3.390

2.  Ontario and New Zealand Pharmaceuticals: Cost and Coverage.

Authors:  Leah T Kelley; Tim Tenbensel; Ana Johnson
Journal:  Healthc Policy       Date:  2018-05

3.  Can cost-effectiveness results be combined into a coherent league table? Case study from one high-income country.

Authors:  Nick Wilson; Anna Davies; Naomi Brewer; Nhung Nghiem; Linda Cobiac; Tony Blakely
Journal:  Popul Health Metr       Date:  2019-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.